Microbot Medical Inc. at its meeting held on November 2, 2023 approved the ratification of Brightman Almagor Zohar & Co., a Member of Deloitte Touche Tohmatsu Limited, or its U.S. affiliate, as the Company?s independent registered public accounting firm for the year ending December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.095 USD | 0.00% |
|
+1.39% | -33.23% |
07-08 | Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System | MT |
07-08 | Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial | CI |
![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-33.23% | 17.48M | |
+25.83% | 47.96B | |
+45.94% | 41.47B | |
+0.69% | 42.45B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |
- Stock Market
- Equities
- MBOT Stock
- News Microbot Medical Inc.
- Microbot Medical Inc. Approves Ratification of Brightman Almagor Zohar & Co. as Independent Registered Public Accounting Firm